# Genetic-Dependent Cardiovascular Response to PPAR-Alpha Agonist Fenofibrate

> **NCT05542147** · NA · COMPLETED · sponsor: **Mario Luca Morieri** · enrollment: 200 (actual)

## Conditions studied

- Type 2 Diabetes
- Cardiovascular Diseases
- Pharmacogenomic Drug Interaction

## Interventions

- **DRUG:** Fenofibrate 145 mg
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05542147
- **Lead sponsor:** Mario Luca Morieri
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-07-03
- **Primary completion:** 2024-11-30
- **Final completion:** 2024-11-30
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2025-08-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05542147

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05542147, "Genetic-Dependent Cardiovascular Response to PPAR-Alpha Agonist Fenofibrate". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT05542147. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*